Cross-species transcriptomic analysis of mouse and rat lung exposed to chloroprene.

β-Chloroprene (2-chloro-1,3-butadiene), a monomer used in the production of neoprene elastomers, is of regulatory interest due to the production of multiorgan tumors in mouse and rat cancer bioassays. A significant increase in female mouse lung tumors was observed at the lowest exposure concentration of 12.8 ppm, whereas a small, but not statistically significant increase was observed in female rats only at the highest exposure concentration of 80 ppm. The metabolism of chloroprene results in the generation of reactive epoxides, and the rate of overall chloroprene metabolism is highly species dependent. To identify potential key events in the mode of action of chloroprene lung tumorigenesis, dose-response and time-course gene expression microarray measurements were made in the lungs of female mice and female rats. The gene expression changes were analyzed using both a traditional ANOVA approach followed by pathway enrichment analysis and a pathway-based benchmark dose (BMD) analysis approach. Pathways related to glutathione biosynthesis and metabolism were the primary pathways consistent with cross-species differences in tumor incidence. Transcriptional BMD values for the pathway were more similar to differences in tumor response than were estimated target tissue dose surrogates based on the total amount of chloroprene metabolized per unit mass of lung tissue per day. The closer correspondence of the transcriptional changes with the tumor response is likely due to their reflection of the overall balance between metabolic activation and detoxication reactions, whereas the current tissue dose surrogate reflects only oxidative metabolism.

[1]  W. P. Watson,et al.  Identification of adducts derived from reactions of (1-chloroethenyl)oxirane with nucleosides and calf thymus DNA. , 2002, Chemical research in toxicology.

[2]  W. P. Watson,et al.  In vitro metabolism of chloroprene: species differences, epoxide stereochemistry and a de-chlorination pathway. , 2001, Chemical research in toxicology.

[3]  S. C. Carpenter,et al.  Kinetic modeling of beta-chloroprene metabolism: I. In vitro rates in liver and lung tissue fractions from mice, rats, hamsters, and humans. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  Russell S. Thomas,et al.  Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  A. Visvikis,et al.  The changing faces of glutathione, a cellular protagonist. , 2003, Biochemical pharmacology.

[6]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[7]  R. J. Rowe,et al.  DNA interstrand cross-linking activity of (1-Chloroethenyl)oxirane, a metabolite of beta-chloroprene. , 2010, Chemical research in toxicology.

[8]  J. Trent,et al.  Microarrays and toxicology: The advent of toxicogenomics , 1999, Molecular carcinogenesis.

[9]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[10]  Michael B. Black,et al.  Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Harvey J Clewell,et al.  Kinetic modeling of β-chloroprene metabolism: Probabilistic in vitro-in vivo extrapolation of metabolism in the lung, liver and kidneys of mice, rats and humans. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  Elaina M Kenyon,et al.  Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  J. Lynch Occupational exposure to butadiene, isoprene and chloroprene. , 2001, Chemico-biological interactions.

[14]  I. Pagan Chloroprene: overview of studies under consideration for the development of an IRIS assessment. , 2007, Chemico-biological interactions.

[15]  D. Posada,et al.  Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. , 2004, Systematic biology.

[16]  V. Feron,et al.  Chronic inhalation toxicity and carcinogenicity studies on β-chloroprene in rats and hamsters , 1998 .

[17]  W. P. Watson,et al.  The metabolism and molecular toxicology of chloroprene. , 2007, Chemico-biological interactions.

[18]  In vitro genotoxicity testing of (1-chloroethenyl)oxirane, a metabolite of beta-chloroprene. , 2001, Chemico-biological interactions.

[19]  H J Clewell,et al.  Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. , 2001, The Science of the total environment.

[20]  Melvin E. Andersen,et al.  Integrating pathway-based transcriptomic data into quantitative chemical risk assessment: a five chemical case study. , 2012, Mutation research.

[21]  R Julian Preston,et al.  Quantitation of molecular endpoints for the dose-response component of cancer risk assessment. , 2002, Toxicologic pathology.

[22]  H. Akaike,et al.  Information Theory and an Extension of the Maximum Likelihood Principle , 1973 .

[23]  M. Andersen,et al.  COMPARING RESPIRATORY-TRACT AND HEPATIC EXPOSURE-DOSE RELATIONSHIPS FOR METABOLIZED INHALED VAPORS: A PHARMACOKINETIC ANALYSIS , 2002, Inhalation toxicology.

[24]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[25]  J. Bukowski Epidemiologic Evidence for Chloroprene Carcinogenicity: Review of Study Quality and its Application to Risk Assessment , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[26]  S. C. Carpenter,et al.  The metabolism of beta-chloroprene: preliminary in-vitro studies using liver microsomes. , 2001, Chemico-biological interactions.

[27]  Harvey J Clewell,et al.  A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.